(Q43690992)

25 November 2017

title

Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study (English)

1 reference

25 November 2017

main subject

obstructive sleep apnea

1 reference

1 reference

Nigel McArdle

1

1 reference

25 November 2017

David Hillman

series ordinal

2

1 reference

25 November 2017

Lawrie Beilin

series ordinal

3

1 reference

25 November 2017

Gerald Watts

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

26 October 2006

1 reference

American Journal of Respiratory and Critical Care Medicine

25 November 2017

published in

1 reference

25 November 2017

volume

175

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

190-195

1 reference

The occurrence of sleep-disordered breathing among middle-aged adults

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Sleep-disordered breathing, glucose intolerance, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Sleep apnoea and sympathetic nervous system activity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Statistics and ethics in medical research: III How large a sample?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Obstructive sleep apnea is independently associated with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Association of habitual snoring with glucose and insulin metabolism in nonobese Korean adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Serum leptin and vascular risk factors in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Growth hormone deficiency and vascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200602-270OC

10.1164/RCCM.200602-270OC

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference